Not Rated
|
Fund Size
(0.25% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 25-Nov-25 | 10005.70 | 0.06% | - | 0.69% | 204/230 |
| 1 Month | 31-Oct-25 | 10002.10 | 0.02% | - | 0.15% | 120/231 |
| 3 Month | 02-Sep-25 | 10109.70 | 1.10% | - | 3.86% | 186/226 |
| 6 Month | 02-Jun-25 | 10586.90 | 5.87% | - | 5.95% | 99/215 |
| YTD | 01-Jan-25 | 9761.40 | -2.39% | - | 5.45% | 164/200 |
| 1 Year | 02-Dec-24 | 10146.10 | 1.46% | 1.46% | 4.29% | 124/189 |
| 2 Year | 01-Dec-23 | 14450.50 | 44.51% | 20.15% | 17.73% | 40/144 |
| 3 Year | 02-Dec-22 | 18704.10 | 87.04% | 23.19% | 19.29% | 27/118 |
| 5 Year | 02-Dec-20 | 23083.70 | 130.84% | 18.20% | 20.96% | 60/93 |
| Since Inception | 28-Dec-15 | 35890.50 | 258.91% | 13.72% | 13.91% | 129/202 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 02-Dec-24 | 12000 | 12467.67 | 3.9 % | 7.28 % |
| 2 Year | 01-Dec-23 | 24000 | 26901.2 | 12.09 % | 11.37 % |
| 3 Year | 02-Dec-22 | 36000 | 48653.28 | 35.15 % | 20.54 % |
| 5 Year | 02-Dec-20 | 60000 | 96235.84 | 60.39 % | 18.95 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 1270.9 | 9.59% | -0.44% | 12.8% (Apr 2025) | 9.59% (Oct 2025) | 7.52 L | -0.64 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 680 | 5.13% | 0.07% | 7.19% (Jun 2025) | 3.31% (Nov 2024) | 88.53 k | 0.00 |
| Healthcare Global Enterprises Ltd. | Hospital | 657.6 | 4.96% | 0.28% | 4.96% (Oct 2025) | 2.15% (Dec 2024) | 8.80 L | -0.62 L |
| Lupin Ltd. | Pharmaceuticals | 649.7 | 4.90% | 0.02% | 7.51% (Dec 2024) | 4.58% (Jun 2025) | 3.31 L | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 624.4 | 4.71% | 0.76% | 4.71% (Oct 2025) | 0% (Nov 2024) | 5.44 L | 85.26 k |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 599.5 | 4.52% | -0.16% | 4.68% (Sep 2025) | 1.83% (May 2025) | 1.68 L | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 586.1 | 4.42% | -0.04% | 4.46% (Sep 2025) | 2.9% (Jun 2025) | 1.06 L | 0.00 |
| Abbott India Ltd. | Pharmaceuticals | 533.1 | 4.02% | 1.12% | 4.02% (Oct 2025) | 0% (Nov 2024) | 18.39 k | 5.54 k |
| Cipla Ltd. | Pharmaceuticals | 519.6 | 3.92% | -0.94% | 6.92% (Aug 2025) | 3.92% (Oct 2025) | 3.46 L | -0.73 L |
| Ipca Laboratories Ltd. | Pharmaceuticals | 471.2 | 3.56% | 0.36% | 3.56% (Oct 2025) | 1.54% (Jun 2025) | 3.71 L | 60.61 k |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| Repo | Repo | 0.98% |
| Net Receivables | Net Receivables | 0.55% |
Ratios calculated on daily returns for last 3 years (Updated as on 28th November, 2025)
Out of 62 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 3 is/are ranked 4 * , 10 is/are ranked 3 * , 3 is/are ranked 2 * , 4 is/are ranked 1 * , and 41 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Tata Money Market Fund - Direct Plan - Growth | 3 | 38052.93 | 0.54 | 1.55 | 3.33 | 7.79 | 7.80 |
| Tata Liquid Fund - Direct Plan - Growth | 2 | 22366.44 | 0.48 | 1.46 | 2.98 | 6.73 | 7.07 |
| Tata Arbitrage Fund - Direct Plan - Growth | 5 | 20106.78 | 0.62 | 1.56 | 3.27 | 7.25 | 7.88 |
| Tata Digital India Fund - Direct Plan - Growth | NA | 11794.37 | 3.09 | 4.16 | 3.50 | -8.34 | 14.16 |
| Tata Small Cap Fund - Direct Plan - Growth | 3 | 11792.26 | -4.65 | -5.23 | -3.91 | -11.09 | 17.38 |
| Tata Balanced Advantage Fund - Direct Plan - Growth | NA | 9906.25 | 0.86 | 4.21 | 4.61 | 6.59 | 12.02 |
| Tata Value Fund - Direct Plan - Growth | 2 | 8881.65 | 2.08 | 7.54 | 7.20 | 3.42 | 19.91 |
| Tata Large & Mid Cap Fund - Direct Plan - Appreciation | 1 | 8828.82 | -0.28 | 3.19 | 2.62 | 1.75 | 13.64 |
| Tata Ultra Short Term Fund - Direct Plan - Growth | 3 | 5490.83 | 0.55 | 1.60 | 3.39 | 7.60 | 7.60 |
| Tata Mid Cap Fund - Direct Plan - Growth | 3 | 5282.94 | 1.85 | 5.84 | 9.35 | 6.18 | 22.48 |